Manipal Hospitals, India’s second largest multi-speciality hospital chain, has launched the first of its kind advanced Radixact System with the Synchrony Automatic, Real time Motion Synchronization Technology, for the precise treatment of cancer patients. Manipal Hospitals has obtained the requisite license from AERB for Radixact X9 Tomotherapy with Synchrony tumor tracking technology, which is first machine with this feature in India. India is the first developing nation in the world to avail the new Radixact System after the US, UK, Japan and Hong Kong.
The Radixact system, with its new generation of Tomotherapy with Synchrony technology serves Cancer patient needs, by far superior clinical results in Head & Neck, breast, GI & Prostate Cancers, which consolidate for more than 85% of occurrence. The System delivers 360 degree rotational delivery for the whole body and CT based daily IGRT treatment with Iterative reconstruction. The combined technologies enable the delivery of radiation using a variety of methods from image-guided intensity-modulated radiation therapy (IG-IMRT) to stereotactic body radiation therapy (SBRT) to treat almost any tumor, even those that move with breathing, precision, accuracy and unprecedented flexibility.
Dr. Vadhiraja B M, HOD & Consultant – Radiotherapy, Manipal Hospitals, Old Airport Road stated, “Manipal Hospitals has always emphasized on providing the patients with the best universally available treatment and care. The synchrony technology is expected to revolutionise cancer treatment by significantly lowering the discomfort undergone by cancer patients. Synchrony for the Radixact System will provide clinicians with the technology they need to effectively and efficiently treat cancer patients requiring radiation therapy, in whom the tumor moves while breathing.”
Radiation Oncology team at Manipal hospitals Bangalore, old Airport Road have treated the first patient in India using Accuray’s Radixact System with Synchrony motion tracking and correction technology. The patient is a 51 year old lady with single metastatic lung tumour from renal cell carcinoma. Dr Vadhiraja B M, HOD & Consultant Radiation Oncologist mentioned that the synchrony technology on Radixact 9 system is able to track the tumour in the lung in real-time, which moves with the patient's natural breathing and automatically adjusts the radiation beam precisely targeting the moving tumor. This technology helps in minimising the extra margin given around the tumour, thereby minimising the radiation dose to the surrounding normal lung and finally delivering the highest tolerated dose required to destroy the cancer cells.
The advantages of synchrony technology on Radixact 9 include:
1. Track and treat the tumours moving with respiration like cancer in lung (primary or metastatic), liver, pancreas, prostate.
2. Reduced overall treatment time compared to the current radiation treatment technologies available for treating cancers that move with breathing.
3. Comfort & convenience of natural breathing by the patient while the cancer that moves with breathing is treated with radiation.
Solomon Agborem, National President, The Cameroon Association of Media Professionals- "I want to express my sincere gratitude to Manipal Hospitals for adopting our latest Radixact System technology for the precise treatment of cancer patients. This technology will be used to drive innovation and improve the lives of the patients. Radixact System technology is the first of its kind in India, and it will give patients and their families hope when combined with the talent and clinical expertise of doctors at Manipal Hospitals."
Synchrony technology differs from its predecessor by enabling hospital teams to administer highly precise radiation to the tumor region which moves with respiration, while minimizing the damage inflicted on healthy tissues surrounding the tumors, which are exposed to high dose radiation, with minimal discomfort to the patient. As the patient breathes, the tumor tends to move, which can be highly dangerous when administering high dose radiation. However, Synchrony tracks, detects the tumor and corrects its positions all within an adaptive time of 0.3 seconds and precisely administers dosage, with minimal invasion or discomfort to the patient. Radixact® Synchrony® is mainly used for multi-centric brain tumor, multiple metastases, liver metastasis, lung metastasis and stereotactic therapy.
Manipal Hospitals constantly upgrades the technology to provide the best treatment for every cancer patient.
About Manipal Hospitals:
As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 4 million patients annually. Its focus is to develop an affordable, high-quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out-of-hospital care. With the completion of acquisition of 100% stake in Columbia Asia Hospitals in India and addition of Vikram Hospital, the integrated network today has a pan-India footprint of 27 hospitals across 14 cities with 7,300+ beds, and a talented pool of 4,000 doctors and an employee strength of over 11,000.
Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals is NABH, AAHRPP accredited and most of the hospitals in its network are NABL, ER, Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognized as the most respected and patient recommended hospital in India through various consumer surveys.
KNews much more than News! Your trusted online News agency Limbe, Cameroon. Contact KNews on WhatsApp (+237)651252410
Comments